CSF3 and neutropenia: If grade 3 or 4 neutropenia develops during treatment, consider delaying dosing, reducing the dose, discontinuing therapy, or administering granulocyte colony-stimulating factor (G-CSF) prophylaxis alongside subsequent BV doses [26].